Pharmaceutical Preparations · DE · CIK 1396814
Pacira BioSciences delivers innovative, non-opioid pain therapies including EXPAREL, ZILRETTA, and iovera°
Comparable business profile · signals at a glance
In the 90 days to Mar 17, 2026: 4 sold $473K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Slonin JonathanChief Medical Officer | Sell | 3,261 | $22.82 | $74K |
| Mar 17, 2026 | Froimson MarkDirector | Sell | 500 | $21.81 | $11K |
| Feb 2, 2026 | Williams KristenChief Administrative Officer | Sell | 13,137 | $20.53 | $270K |
| Feb 2, 2026 | Riker LaurenSenior Vice President, Finance | Sell | 4,000 | $20.81 | $83K |
| Jan 5, 2026 | Riker LaurenSenior Vice President, Finance | Sell | 1,416 | $24.24 | $34K |
| Dec 10, 2025 | Cross ShawnChief Financial Officer | Sell | 9,104 | $25.14 | $229K |
| Dec 9, 2025 | Cross ShawnChief Financial Officer | Sell | 15,896 | $25.03 | $398K |
| Nov 17, 2025 | Slonin JonathanChief Medical Officer | Sell | 3,960 | $24.09 | $95K |
| Nov 10, 2025 | Cross ShawnChief Financial Officer | Sell | 12,060 | $22.09 | $266K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.